Jan Kriz
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Consolidative Thoracic Radiotherapy With Atezolizumab Maintenance in Extensive-Stage Small Cell Lung Cancer: The Phase 2 TREASURE Randomized Clinical Trial (AIO-TRK-0320).
Journal: JAMA oncology
Published: July 09, 2026
Risk of radiation-induced malignancy after low-dose radiotherapy for non-malignant musculoskeletal disorders: A long-term retrospective analysis of n=4699 patients.
Journal: International journal of radiation oncology, biology, physics
Published: April 09, 2026
Three-dimensional treatment planning and target volume definition of tendinitis and bursitis - Consensus statement of the International Benign Target Volume Group (IBTVG).
Journal: International journal of radiation oncology, biology, physics
Published: March 10, 2026
Beyond Malignancy: Addressing the Educational Gap in Radiation Therapy for Nonmalignant Diseases.
Journal: Practical radiation oncology
Published: January 28, 2026
Three-Dimensional Radiation Therapy Target Volume Definitions for Osteoarthritis-Consensus Statement of the International Benign Target Volume Group.
Journal: International journal of radiation oncology, biology, physics
Published: November 09, 2025
130 Years of Radiotherapy for Nonmalignant Diseases: A Historical Overview.
Journal: Seminars in radiation oncology
Published: October 18, 2025
Radiotherapy for Other Nonmalignant Diseases.
Journal: Seminars in radiation oncology
Published: September 26, 2025
Radiation Therapy for Nonmalignant Diseases: An ASTRO-ESTRO-DEGRO-RANZCR Framework.
Journal: International journal of radiation oncology, biology, physics
Published: September 07, 2025
From essential basic understanding to clinical application - biological, physical and pathophysiological principles of (low-dose) radiotherapy in benign diseases.
Journal: Frontiers in immunology
Published: March 05, 2025
Radiation doses to mediastinal organs at risk in early-stage unfavorable Hodgkin lymphoma- a risk stratified analysis of the GHSG HD17 trial.
Journal: Frontiers in oncology
Published: March 10, 2023
Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era.
Journal: Advances in radiation oncology
Published: December 21, 2022
The Role of Radiotherapy for Patients With Thyroid Cancer in the Modern Era.
Journal: Anticancer research
Published: April 02, 2020
Last Updated: 09/26/2026